Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Novartis day

Novartis’ Swiss head of operations reveals job cuts

Leuenberger suggests cuts are needed to maintain competiveness

- PMLiVE

Merck takes on Roche with first-line bladder OK for Keytruda

FDA awards accelerated approval for mUC patients

- PMLiVE

Merck and Pfizer claim second FDA nod for cancer drug Bavencio

Analysts predict it will bring in sales of around $600m by 2020

- PMLiVE

UMG acquires Europharma

Will attain the firm’s e-learning programmes

- PMLiVE

The new science of content marketing

The role of big data and artificial intelligence  in marketing and advertising

- PMLiVE

Astellas appoints new senior VP

Shontelle Dodson also takes on head of Medical Affairs Americas role

Award-winning medical communications agency Porterhouse Medical opens new office space.

 *Friday 12th May, 2017; Reading, UK – Reading-based Porterhouse Medical, winner of the Queen’s Award for Enterprise, was delighted to welcome Rob Wilson MP to open their new office in...

Porterhouse Medical Group

- PMLiVE

FDA broadens use of cystic fibrosis drug Kalydeco

Drug now available to more patients in the US

- PMLiVE

J&J aiming for above-average growth thanks to stream of blockbusters

US firm enters highly productive R&D phase

- PMLiVE

Cello Health Communications strengthens its European efforts

Firm re-brands its communication offerings

- PMLiVE

GW Pharmaceuticals strengthens research and development team

Appoints Dr Volker Knappertz and Professor Ben Whalley

Bayer symbol

Bayer’s lymphoma drug copanlisib gets speedy FDA review

The PI3K inhibitor will be assessed for relapsed or refractory follicular lymphoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links